Table 3.
Oxidative stress parameters (mean value ± standard deviation SD) in AS patients before and after the treatment in studied groups.
| Parameters | WBC Group | ET Group | p | |
|---|---|---|---|---|
| LHP (s) (μmol/L) | Before | 19.9 ± 23.7 | 14.3 ± 6.8 | 0.957 |
| After | 9.47 ± 17.0 | 13.8 ± 21.9 | 0.537 | |
| P* | 0.001 | 0.008 | ||
| Lipofuscin (e) (RF/gHb) | Before | 225 ± 43.6 | 201 ± 36.9 | 0.101 |
| After | 41.9 ± 16.5 | 46.4 ± 31.8 | 0.623 | |
| P* | <0.001 | <0.001 | ||
| PON-1 (s) (IU/L) | Before | 163.3 ± 74.9 | 185.5 ± 85.6 | 0.441 |
| After | 132.2 ± 71.0 | 166 ± 82.8 | 0.224 | |
| P* | 0.015 | 0.03 | ||
| PSH (s) (μmol/L) | Before | 402.6 ± 91.7 | 393.2 ± 90.0 | 0.872 |
| After | 616.5 ± 279.1 | 364.7 ± 28.4 | 0.339 | |
| P* | 0. 921 | 0.017 | ||
| Albumin (s) (g/L) | Before | 38.93 ± 2.29 | 40.59 ± 2.32 | 0.060 |
| After | 42.98 ± 2.13 | 41.26 ± 2.38 | <0.001 | |
| P* | 0.044 | 0.756 | ||
WBC group: AS patients exposed to whole-body cryotherapy and exercise training; ET group: AS patients exposed only to exercise training; LHP: lipid hydroperoxide; PON-1: paraoxonase-1; PSH: protein sulfhydryl; P*: statistical significance of differences between values before and after treatment in particular groups of subjects; P: statistical significance of differences between both groups of subjects; (e): erythrocyte lysates; (p): plasma; (s): serum.